Search

Learn about the difference methods of colorectal cancer screening, including the at-home Cologuard test, from an expert at Memorial Sloan Kettering Cancer Center.

… Monday, March 16, 2026 You probably know that at age 45, people at average risk are advised to begin screening for colorectal cancer. And you may be aware of various screening methods, particularly colonoscopy and the widely advertised at-home test called Cologuard®. But many people have questions about

Obtenga información sobre los diferentes métodos de detección de cáncer colorrectal, incluso la prueba casera Cologuard, de una experta de Memorial Sloan Kettering Cancer Center.

… Monday, March 16, 2026 Usted probablemente sepa que, a partir de los 45 años de edad, se recomienda que las personas que corren riesgo promedio de padecer cáncer colorrectal comiencen a hacerse pruebas de detección de dicha enfermedad. También puede que conozca diversos métodos de diagnóstico, en particular

Узнайте о способах обследования на наличие рака толстой и прямой кишки, в том числе о домашнем анализе Cologuard, у специалиста Memorial Sloan Kettering Cancer Center.

… Monday, March 16, 2026 Возможно, вы знаете, что людям в возрасте от 45 лет со средним уровнем риска развития рака толстой и прямой кишки рекомендовано проходить обследования. Вам также может быть известно о различных способах такого обследования, в частности о колоноскопии и широко разрекламированном

Edward Athanasian discusses the unique challenges of operating on sarcomas and other tumors in the hand.

… Tuesday, July 24, 2018 Summary Edward Athanasian is the only surgeon in the United States who is trained in both surgical oncology and hand surgery. He is also Chief of the Hand and Upper Extremity Service at the Hospital for Special Surgery in New York City. Sarcoma is not one distinct cancer but more

Hail to the zebrafish. MSK scientists are using a small fish to answer some big questions about cancer.

… Friday, January 29, 2016 Summary Physician and cell biologist Richard White is using zebrafish to study cancer development. The fish are generating new insights into why only certain cells with genetic mutations turn into cancer and how these cells spread to other parts of the body. Highlights Zebrafish

Read about clinical trial results showing that a liquid biopsy helped select cancer patients for effective immunotherapy treatment.

… Sunday, April 27, 2025 A small pilot study led by researchers at Memorial Sloan Kettering Cancer Center (MSK) has found that a simple blood test can help doctors identify which patients are most likely to benefit from immunotherapy after cancer surgery to remove tumors — potentially preventing the disease

Lea los resultados de ensayos clínicos que demuestran que una biopsia líquida ayudó a seleccionar a pacientes con cáncer para recibir un tratamiento de inmunoterapia eficaz.

… Sunday, April 27, 2025 Un pequeño estudio piloto dirigido por investigadores de Memorial Sloan Kettering Cancer Center (MSK) descubrió que un simple análisis de sangre puede ayudar a los médicos a identificar qué pacientes tienen más probabilidades de beneficiarse de la inmunoterapia después de la cirugía

Five Memorial Sloan Kettering (MSK) faculty were named today to the prestigious Fellows of the American Association for Cancer Research (AACR) Academy Class of 2022.

… Tuesday, March 22, 2022 Five Memorial Sloan Kettering (MSK) faculty are among the 33 international scientific leaders elected today to the prestigious Fellows of the American Association for Cancer Research (AACR) Academy class of 2022. Luis Alberto Diaz Jr., MD; Thomas J. Kelly, MD, PhD; Nikola P. Pavletich

Mark H. Bilsky has been named one of the 28 top spine surgeons in North America by Orthopedics This Week.

… Tuesday, July 16, 2013 Mark H. Bilsky has been named one of the 28 top spine surgeons in North America by Orthopedics This Week . The publication surveyed leading spine surgeons and asked them to select the best of their peers. Dr. Bilsky is director of Memorial Sloan Kettering’s multidisciplinary spine

Learn how a family with a young son diagnosed with Ewing sarcoma were helped by the experts at MSK Kids, the pediatric oncology program at Memorial Sloan Kettering Cancer Center.

… Wednesday, September 28, 2022 Gus Frank is seen smiling with his older sister. Gus was treated for Ewing Sarcoma at MSK Kids, the pediatric oncology program at Memorial Sloan Kettering Cancer Center Gus Frank (left) with his older sister Susan. Gus is being cared for by MSK Kids, the pediatric oncology